The disease claims millions of lives each year. The WHO report states that cancer will be responsible for almost 10 million deaths in 2020. Lung cancer is the most prevalent cancer among the different types, with 2.21 million cases expected in 2020.
The number of cancer cases and related mortality rates are predicted to increase further in the coming years as a result of significant factors like rising air pollution and risky smoking habits among people. In the United States, 224,000 new cases of lung cancer are anticipated to be diagnosed by the year 2030. According to cancer.net, in 2022, there are expected to be 130,180 lung and bronchus cancer deaths in the
United States and approximately 236,740 new cases of the disease.
The mortality rate and alarmingly high prevalence have placed an unprecedented strain on the healthcare system. Researchers and healthcare professionals are working to develop effective cancer diagnostic and treatment procedures by making the best use of the cutting-edge technology that is currently available.
One such approach that has recently attracted the attention of experts is lung cancer genomic testing. In order to pinpoint the precise type of mutation that differs depending on each person's genetic makeup, a molecular analysis of the tumour is performed. This procedure aids the medical professionals in selecting the most suitable course of action for a specific patient.
Despite the fact that the global market for lung cancer genomic testing is still in its infancy, numerous businesses are making significant investments in R&D to advance the field.
The transition of healthcare systems toward precision diagnostic and precision medicine is responsible for the increase in the adoption of lung cancer genomic testing. The use of cutting-edge technology facilitates making well-informed decisions and leads to better cancer treatment outcomes. Significant opportunities exist in the global lung cancer genomic testing market as a result of rising recommendations from international oncology societies for the use of genomic testing for lung cancer diagnosis.
According to a BIS Research report, the lung cancer genomic testing medicine market was estimated to be worth $1.26 billion in 2020 and is projected to reach $3.27 billion by 2031, growing at a CAGR of 8.97% over the forecast period of 2021–2031.
Causes and Risks of Lung cancer
It is critical to comprehend the disease's underlying causes, risks, and solutions in order to increase public awareness and educate people about its dangers. The same will be covered in more detail in this article. Some possible cancer causes include the ones listed below:
Risk factors leading to lung cancer
1. Smoking- Smoking is the most hazardous habit acquired by humans. It is considered to be the number one cause of lung cancer as 90% of lung cancer cases are attributed to the extreme smoking habits in the patients. Tobacco smoke contains many dangerous chemicals that are known to cause lung cancer.
The chemicals released from cigarette smoke do harm not only the smokers but also the people around them inhaling the smoke through the air. Breathing second-hand smoke puts people at risk for lung cancer or other respiratory illnesses.
2. Exposure to some hazardous chemicals, including asbestos, uranium, arsenic, cadmium, chromium, nickel, and petroleum, increases the risk of lung cancer. The risk of cancer is higher for those who live close to the industries that emit these chemicals.
3. Particle Pollution: The air is filled with a mixture of minuscule solid and liquid particles that are extremely hazardous to human health due to a variety of air pollution causes, including factories, vehicles, mining operations, etc. There is evidence that the risk of lung cancer is increased by air pollution particles.
4. Genes: One's likelihood of developing lung cancer is significantly influenced by genetic factors. A person's risk of developing lung cancer may increase if there is a family history of the disease. It is crucial to seek medical advice and exercise caution if someone in the family currently has lung cancer or has ever had the disease.
To get a free sample of the report, click here - https://bisresearch.com/requestsample?id=1301&type=download
One such difficult and dangerous disease for which people have spent centuries trying to find a cure is cancer. But thanks to technological advancements, the healthcare sector has made remarkable strides in slowing the spread of the disease and enabling accurate early diagnosis. One such instance of a sophisticated diagnostic tool that has helped many
Interested to know more about the growing technologies in your industry vertical? Get the latest market studies and insights from BIS Research. Connect with us at https://bisresearch.com/contact-us
No comments:
Post a Comment